We are running a very special FEMS Webinar on Vaccines in the Time of COVID-19, featuring top figures in the field of vaccine research and development. This webinar promises to be inspiring and informative and we really hope you can attend, as this vitally important subject is the key to ending the ongoing COVID-19 pandemic for all of us. Date: Wednesday 10th March 2021 Time: 10am EST / 3pm GMT / 4pm CET / 11pm CST Join us for a webinar on the vitally important subject of vaccines, featuring: Chair: Dr Alfredo Garzino-Demo (image: left) Editor-in-Chief of Pathogens and Disease and Associate Professor at the Institute of Human Virology, and the Department of Microbiology and Immunology of the University of Maryland School of Medicine (USA); and at the University of Padova (Italy) Dr Kizzmekia Corbett, National Institutes of Health, USA (image: centre left) Dr Kizzmekia Corbett is a research fellow and the scientific lead for the Coronavirus Vaccines and Immunopathogenesis Team at the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases, Vaccine Research Center (VRC). A viral immunologist by training, Dr Corbett uses her expertise to propel novel vaccine development for pandemic preparedness. In response to the ongoing global COVID-19 pandemic, the vaccine concept incorporated in mRNA-1273 was designed by Dr Corbett’s team from viral sequence data and rapidly deployed to industry partner Moderna. Dr Florian Krammer, Icahn School of Medicine at Mount Sinai, USA (image: centre right) Dr Florian Krammer is a Professor of Vaccinology at the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and since 2019 has been the Principal Investigator of the Sinai-Emory Multi-Institutional Collaborative Influenza Vaccine Innovation Center (SEM-CIVIC). The Krammer laboratory, also part of the NIH-funded Centers for Excellence in Influenza Research and Surveillance, focuses on understanding broadly-reactive immune responses against the surface glycoproteins of RNA viruses such as influenza with the goal to develop better vaccines and novel therapeutics Dr Rino Rappuoli, GSK Vaccines, Italy (image: right) Dr Rino Rappuoli is Chief Scientist and Head External R&D at GSK Vaccines, and Professor of Vaccines Research at Imperial College, London, UK. Dr Rappuoli has introduced several novel scientific concepts over the course of his career; examples include genetic detoxification, cellular microbiology, reverse vaccinology, and observation of the pangenome. He has been instrumental to the development of many vaccines, including those against H. influenzae, N. meningitidis, pneumococcus, pertussis, and meningitis. He is an author on the recent microLife paper: Development of vaccines at the time of COVID-19. |